| Zacks Company Profile for Sysmex Corporation ADR (SSMXY : OTC) |
|
|
| |
| • Company Description |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan.
Number of Employees: 11,457 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $11.95 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 259,416 shares |
| Shares Outstanding: 629.48 (millions) |
| Market Capitalization: $7,522.29 (millions) |
| Beta: 1.16 |
| 52 Week High: $22.00 |
| 52 Week Low: $11.31 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-1.65% |
-3.60% |
| 12 Week |
-26.78% |
-31.11% |
| Year To Date |
-34.63% |
-42.94% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
1-5-1 Wakihama Kaigan-dori Chuo-ku
-
Kobe,M0 651-0073
JPN |
ph: 817-8265-0500
fax: 817-8265-0524 |
None |
http://www.sysmex.co.jp |
|
|
| |
| • General Corporate Information |
Officers
Tsune Ietsugu - Group Chief Executive Officer;Chairman and Directo
Kaoru Asano - President;Chief Executive Officer and Director
Tomokazu Yoshida - Chief Technology Officer and Director
Kazuo Ota - Director
Haruo Inoue - Director
|
|
Peer Information
Sysmex Corporation ADR (ABMD)
Sysmex Corporation ADR (DMDS)
Sysmex Corporation ADR (CPWY.)
Sysmex Corporation ADR (EQUR)
Sysmex Corporation ADR (ECIA)
Sysmex Corporation ADR (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 87184P109
SIC: 8880
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/05/25
|
|
Share - Related Items
Shares Outstanding: 629.48
Most Recent Split Date: 4.00 (1.50:1)
Beta: 1.16
Market Capitalization: $7,522.29 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 1.33% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.16 |
| Current Fiscal Year EPS Consensus Estimate: $0.56 |
Payout Ratio: 0.32 |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: 0.03 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/05/25 |
|
|
|
| |
